Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,976,965 | 4,133,304 | 18,238,450 | 22,451,330 | 550,960 |
| Cost of Goods | 585,741 | 649,164 | 3,155,532 | 3,444,596 | 67,776 |
| Gross Profit | 2,391,225 | 3,484,140 | 15,082,920 | 19,006,740 | 483,184 |
| Operating Expenses | 3,814,169 | 2,737,084 | 1,763,099 | 925,070 | 578,105 |
| Operating Income | -1,422,204 | 747,220 | 13,320,350 | 18,082,260 | -94,145 |
| Interest Expense | 29,650 | 25,867 | 19,913 | 360,964 | 74,191 |
| Other Income | 718,514 | 562,363 | 348,003 | 80,104 | 1,787 |
| Pre-tax Income | -733,339 | 1,283,716 | 13,648,440 | 17,801,400 | -166,550 |
| Income Tax | -13,418 | 276,852 | 3,708,356 | 5,624,339 | -183,910 |
| Net Income Continuous | -719,921 | 1,006,864 | 9,940,084 | 12,177,060 | 17,361 |
| Net Income | $-719,921 | $1,006,864 | $9,940,084 | $12,177,060 | $17,361 |
| EPS Basic Total Ops | -3.00 | 4.19 | 40.86 | 49.90 | 0.07 |
| EPS Basic Continuous Ops | -2.99 | 4.18 | 40.86 | 49.91 | 0.07 |
| EPS Diluted Total Ops | -3.00 | 4.15 | 39.79 | 46.89 | 0.07 |
| EPS Diluted Continuous Ops | -2.99 | 4.15 | 39.79 | 46.89 | 0.07 |
| EPS Diluted Before Non-Recurring Items | -3.00 | 4.15 | 39.80 | 46.89 | 0.07 |
| EBITDA(a) | $-1,099,738 | $945,714 | $13,450,260 | $18,171,230 | $-49,888 |